|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.30 SEK | -7.13% |
|
-5.82% | -10.37% |
| 18/07 | BioGaia AB, Q2 2025 Earnings Call, Jul 18, 2025 | |
| 18/07 | BioGaia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 | CI |
| Capitalization | 1.01TCr 105.06Cr 90Cr 84Cr 78Cr 144.18Cr 9.05TCr 160.99Cr 383.02Cr 4.24TCr 394.09Cr 385.92Cr 16TCr | P/E ratio 2025 * |
26.7x | P/E ratio 2026 * | 22.7x |
|---|---|---|---|---|---|
| Enterprise value | 922.96Cr 96Cr 82Cr 76Cr 71Cr 131.15Cr 8.23TCr 146.44Cr 348.41Cr 3.86TCr 358.47Cr 351.05Cr 14TCr | EV / Sales 2025 * |
6.07x | EV / Sales 2026 * | 5.46x |
| Free-Float |
87.96% | Yield 2025 * |
5.38% | Yield 2026 * | 5.38% |
More valuation ratios
* Estimated data
More news
Last Transcript: BioGaia AB
More recommendations
More press releases
More news
| 1 day | -7.13% | ||
| 1 week | -5.82% | ||
| Current month | -5.56% | ||
| 1 month | -0.59% | ||
| 3 months | -0.40% | ||
| 6 months | -11.94% | ||
| Current year | -10.37% |
| 1 week | 98.6 |  | 109.3 |
| 1 month | 97.5 | | 109.3 |
| Current year | 93.5 | | 139.7 |
| 1 year | 93.5 | | 139.7 |
| 3 years | 68.88 | | 139.7 |
| 5 years | 68.88 | | 139.7 |
| 10 years | 39.4 | | 139.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Agnew
CEO | Chief Executive Officer | 59 | 30/09/2023 |
| Director of Finance/CFO | 58 | 05/11/2019 | |
Ludvig Milesson
COO | Chief Operating Officer | 48 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Dangoor
CHM | Chairman | 76 | 01/01/2003 |
| Chairman | 75 | 25/04/2018 | |
Anthon Jahreskog
BRD | Director/Board Member | 45 | 01/01/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.13% | -5.82% | -19.89% | -9.28% | 105.06Cr | ||
| +3.62% | +6.83% | -17.43% | -11.45% | 8.13TCr | ||
| -1.36% | -4.44% | -48.99% | -8.93% | 5.73TCr | ||
| -1.78% | +5.10% | +23.65% | +29.75% | 5.39TCr | ||
| +0.49% | +2.28% | +27.49% | +106.34% | 3.87TCr | ||
| -0.06% | +10.55% | +118.53% | +146.33% | 1.94TCr | ||
| +0.31% | +11.62% | +86.31% | +820.19% | 1.89TCr | ||
| -2.88% | -6.87% | -44.79% | -43.25% | 1.83TCr | ||
| -0.04% | -.--% | +76.16% | +135.78% | 1.4TCr | ||
| -1.57% | -1.06% | +3.02% | -16.59% | 1.31TCr | ||
| Average | -1.04% | +1.35% | +20.41% | +114.89% | 3.16TCr | |
| Weighted average by Cap. | +0.20% | +2.24% | +7.29% | +74.25% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 152.1Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.36TCr 24Cr 57Cr 635.94Cr 59Cr 58Cr 2.34TCr | 170.96Cr 18Cr 15Cr 14Cr 13Cr 24Cr 1.52TCr 27Cr 65Cr 714.78Cr 66Cr 65Cr 2.63TCr |
| Net income | 38Cr 3.93Cr 3.38Cr 3.15Cr 2.93Cr 5.4Cr 338.87Cr 6.03Cr 14Cr 158.88Cr 15Cr 14Cr 584.01Cr | 45Cr 4.62Cr 3.96Cr 3.69Cr 3.44Cr 6.34Cr 397.97Cr 7.08Cr 17Cr 186.59Cr 17Cr 17Cr 685.87Cr |
| Net Debt | -92Cr -9.5Cr -8.15Cr -7.59Cr -7.06Cr -13Cr -817.74Cr -15Cr -35Cr -383.4Cr -36Cr -35Cr -1.41TCr | -81Cr -8.34Cr -7.15Cr -6.66Cr -6.2Cr -11Cr -718.01Cr -13Cr -30Cr -336.64Cr -31Cr -31Cr -1.24TCr |
More financial data
* Estimated data
Employees
224
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/25/18 | 100.30 kr | -7.13% | 5,39,613 |
| 17/25/17 | 108.00 kr | +0.65% | 1,37,432 |
| 16/25/16 | 107.30 kr | -0.09% | 2,29,991 |
| 15/25/15 | 107.40 kr | +1.03% | 2,39,008 |
| 14/25/14 | 106.30 kr | -0.19% | 72,671 |
Delayed Quote Nasdaq Stockholm, July 18, 2025 at 09:30 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.30SEK
Average target price
150.00SEK
Spread / Average Target
+49.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIOG B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition